Literature DB >> 8874113

Autosomal dominant familial Mediterranean fever--like syndrome.

C J Mache1, U Goriup, N Fischel-Ghodsian, X Chen, J Schwingshandl.   

Abstract

UNLABELLED: We report a syndrome characterized by recurrent episodes of fever and serositis in an Austrian family. Three family members over two successive generations were affected. The febrile episodes had their onset at the age of 11-12 years, lasted 1-5 weeks, and occurred in intervals of 6-24 months. While the disorder resembles familial Mediterranean fever (FMF) clinically, ethnic distribution and other features suggest a distinct entity. Clinically, the attacks last longer than the usual FMF attacks, and in the male patients are associated with scrotal inflammation. Genetically, the disorder appears to be inherited as an autosomal dominant syndrome, whereas FMF is autosomal recessive. Molecular analysis made the involvement of a gene in the FMF region of chromosome 16p13.3 highly unlikely.
CONCLUSION: An Austrian family with recurrent fever syndrome is reported. Ethnicity, clinical features, and molecular studies point to a distinct clinical entity.

Entities:  

Mesh:

Year:  1996        PMID: 8874113     DOI: 10.1007/bf02002908

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  Periodic fever: occurrence in five generations.

Authors:  B A BOURONCLE; C A DOAN
Journal:  Am J Med       Date:  1957-09       Impact factor: 4.965

2.  Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16.

Authors:  E Pras; I Aksentijevich; L Gruberg; J E Balow; L Prosen; M Dean; A D Steinberg; M Pras; D L Kastner
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

Review 3.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

4.  Familial Mediterranean fever in an Italian family.

Authors:  C B Reich; E C Franklin
Journal:  Arch Intern Med       Date:  1970-02

5.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

6.  C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever.

Authors:  Y Matzner; A Brzezinski
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

7.  Changes in serum IgD in cigarette smokers.

Authors:  S L Bahna; D C Heiner; B A Myhre
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

8.  Familial Hibernian fever.

Authors:  L M Williamson; D Hull; R Mehta; W G Reeves; B H Robinson; P J Toghill
Journal:  Q J Med       Date:  1982

9.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

10.  [The metaraminol provocation test in the diagnosis of familial Mediterranean fever].

Authors:  H I Huppertz; H Michels
Journal:  Monatsschr Kinderheilkd       Date:  1988-05       Impact factor: 0.323

View more
  3 in total

1.  Linkage of familial Hibernian fever to chromosome 12p13.

Authors:  M F McDermott; B W Ogunkolade; E M McDermott; L C Jones; Y Wan; K A Quane; J McCarthy; M Phelan; M G Molloy; R J Powell; C I Amos; G A Hitman
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Gene localization for an autosomal dominant familial periodic fever to 12p13.

Authors:  J Mulley; K Saar; G Hewitt; F Rüschendorf; H Phillips; A Colley; D Sillence; A Reis; M Wilson
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

Review 3.  IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting.

Authors:  Lori Broderick; Hal M Hoffman
Journal:  Nat Rev Rheumatol       Date:  2022-06-21       Impact factor: 32.286

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.